USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
The Department of Commerce has received 95 requests to include additional products on the list of steel and aluminum derivatives subject to the assessment of 50% ad valorem tariffs under
By: Joseph Spraragen On September 25, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision in favor of the Government in the lead China Section
Insights, News
USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
In light of various factors, including the rise in COVID-19 cases in the U.S. and the ability to obtain certain products from domestic and foreign sources, the USTR is requesting public comments on whether to extend the medical care product exclusions for up to six months. The list of the particular products in question can be found at: https://www.gdlsk.com/ustr-extends-certain-china-301-exclusions-and-designates-additional-exclusions-for-the-period-january-1-march-31-2021/?highlight=medical%20care%20products.
Comments are being accepted through September 27, 2021.
We are available to assist with the preparation of comments and to otherwise discuss China 301 mitigation strategies.
Please do not hesitate to contact Arthur Bodek or any of our attorneys for further information.
Additional News
Commerce Department Posts New Steel and Aluminum Derivative Inclusion Requests – Comments Due October 21
The Department of Commerce has received 95 requests to include additional products on the list of steel and aluminum derivatives subject to the assessment of 50% ad valorem tariffs under
China Section 301 Litigation Update
By: Joseph Spraragen On September 25, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision in favor of the Government in the lead China Section
Additional Insights
GDLSK Partner, Frank Desiderio, to Speak at a Program Entitled “Navigating Policy Impacts and Industry Insights for 2026”
GDLSK partner Frank J. Desiderio will speak as a panelist at a program organized and sponsored by J.P. Morgan and
David M. Murphy to Speak at the NAFTZ Annual Conference
Partner David M. Murphy will speak at the National Association of Foreign Trade Zones Annual Conference & Exposition in Kansas